Guidelines for the management of ovarian cancer during pregnancy
H Marret, C Lhommé, F Lecuru, M Canis… - European Journal of …, 2010 - Elsevier
Adnexal masses may be detected during prenatal ultrasound, and ovarian cancer may be
suspected during pregnancy. Even though such masses are rarely malignant (1/10,000 to …
suspected during pregnancy. Even though such masses are rarely malignant (1/10,000 to …
Results of conservative management of epithelial malignant and borderline ovarian tumours
…, P Pautier, C Pomel, C Lhommé… - Human reproduction …, 2003 - academic.oup.com
Conservative management of at least part of both the ovary and uterus can be proposed in
patients with borderline ovarian tumour, in order to preserve fertility potential. This …
patients with borderline ovarian tumour, in order to preserve fertility potential. This …
The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients
…, S Culine, JP Droz, P Taupin, C Lhommé… - European Journal of …, 2000 - Elsevier
Growing teratoma syndrome (GTS) is defined as an increase in tumour size during or after
chemotherapy for germ cell tumour (GCT), and only mature teratoma at histological analysis …
chemotherapy for germ cell tumour (GCT), and only mature teratoma at histological analysis …
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
…, DM Provencher, BY Karlan, C Lhommé… - The lancet …, 2014 - thelancet.com
Background Angiogenesis is a valid target in the treatment of epithelial ovarian cancer.
Trebananib inhibits the binding of angiopoietins 1 and 2 to the Tie2 receptor, and thereby …
Trebananib inhibits the binding of angiopoietins 1 and 2 to the Tie2 receptor, and thereby …
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
BACKGROUND: The purpose was to determine the factors influencing nodal involvement
and topography of pelvic and paraaortic node involvement in ovarian carcinoma. STUDY …
and topography of pelvic and paraaortic node involvement in ovarian carcinoma. STUDY …
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
…, C Genestie, A Rey, P Morice, B Roche, C Lhommé… - Cancer, 2000 - Wiley Online Library
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a
grading score validated for soft tissue sarcoma - Pautier - 2000 - Cancer - Wiley Online Library …
grading score validated for soft tissue sarcoma - Pautier - 2000 - Cancer - Wiley Online Library …
Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme …
…, P Denizot, H Cailla, C Lhommé… - The Journal of …, 2000 - academic.oup.com
Granulosa cell tumors (GCT) are ovarian neoplasms that tend to recur and spread in the
pelvis and the abdomen several years after the initial treatment. Anti-Müllerian hormone …
pelvis and the abdomen several years after the initial treatment. Anti-Müllerian hormone …
Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum α-inhibin and estradiol
RA Rey, C Lhommé, I Marcillac, N Lahlou… - American journal of …, 1996 - Elsevier
OBJECTIVE: Our purpose was to evaluate serum antimüllerian hormone as a marker for
granulosa cell tumors. STUDY DESIGN: Serum antimüllerian hormone concentrations were …
granulosa cell tumors. STUDY DESIGN: Serum antimüllerian hormone concentrations were …
A phase II trial to evaluate gefitinib as second-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
A Goncalves, M Fabbro, C Lhommé, L Gladieff… - Gynecologic …, 2008 - Elsevier
BACKGROUND.: Cancer of the cervix occurs in∼ 500000 women worldwide each year, with
prognosis highly dependent on disease stage at diagnosis. Survival times are poor and …
prognosis highly dependent on disease stage at diagnosis. Survival times are poor and …
[HTML][HTML] A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients …
…, N Pinto, P Duvillard, C Haie-Meder, C Lhommé… - Annals of …, 2013 - Elsevier
Background There is no proven benefit of adjuvant treatment of uterine sarcoma (US).
SARCGYN phase III study compared adjuvant polychemotherapy followed by pelvic …
SARCGYN phase III study compared adjuvant polychemotherapy followed by pelvic …